Medical Doctor Program year 2022 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Peterson

Neurology Washington, DC Medical Doctor

NPI 1144419227 CMS profile 323929

1140 Varnum St Ne, Suite #101, Washington, DC 20017

Open in the dashboard

General payments

$2,295

126 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$397,416

5 holdings reported · through program year 2022

Through program year 2022, William Peterson of Washington, DC is reported in the CMS Open Payments database as having received $2,295 across 126 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $397,416 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 56th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $58 3
2021 General $393 19
2020 General $1,157 61
2019 General $687 43
2025 Ownership $61,848 1
2024 Ownership $61,848 1
2023 Ownership $61,848 1
2022 Ownership $61,848 1
2021 Ownership $150,022 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Peterson
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to William Peterson were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year William Peterson Neurology median Middle half National median
2019 $687 $474 $118–$2,177 $163
2020 $1,157 $367 $82–$2,309 $114
2021 $393 $438 $104–$2,547 $132
2022 $58 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Supernus Pharmaceuticals, Inc. $1,152 61 payments
  2. Novartis Pharmaceuticals Corporation $205 13 payments
  3. Sunovion Pharmaceuticals Inc. $183 10 payments
  4. E.R. Squibb & Sons, L.L.C. $131 7 payments
  5. Mallinckrodt Hospital Products Inc. $130 6 payments
  6. EMD Serono, Inc. $99 6 payments
  7. Genentech USA, Inc. $93 5 payments
  8. Biogen, Inc. $74 4 payments
  9. Scilex Pharmaceuticals Inc. $54 4 payments
  10. Avanir Pharmaceuticals, Inc. $37 3 payments
  11. Other $136 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,265 124 payments
  2. Education $30 2 payments
Products named General payments · program years 2019–2022
  1. TROKENDI XR $660 34 payments
  2. OXTELLAR XR $606 33 payments
  3. APTIOM $183 10 payments
  4. MAYZENT $155 9 payments
  5. GILENYA $131 8 payments
  6. ZEPOSIA $131 7 payments
  7. ACTHAR $130 6 payments
  8. OCREVUS $93 5 payments
  9. Mavenclad $49 3 payments
  10. KESIMPTA $38 3 payments
  11. Other $357 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

126 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record